Literature DB >> 18775625

Assessing the effectiveness of an Internet-based videoconferencing platform for delivering intensified substance abuse counseling.

Van L King1, Kenneth B Stoller, Michael Kidorf, Kori Kindbom, Steven Hursh, Thomas Brady, Robert K Brooner.   

Abstract

Enhanced schedules of counseling can improve response to routine opioid-agonist treatment, although it is associated with increased time demands that enhance patient resistance and nonadherence. Internet-based counseling can reduce these concerns by allowing patients to participate from home. This study assesses treatment satisfaction and response to Internet-based (CRC Health Group's e-Getgoing) group counseling for partial responders to methadone maintenance treatment. Patients testing positive for an illicit substance (n = 37) were randomly assigned to e-Getgoing or onsite group counseling and followed for 6 weeks. Patients in both conditions responded favorably to intensified treatment by achieving at least 2 consecutive weeks of abstinence and 100% attendance to return to less-intensive care (e-Getgoing: 70% vs. routine: 71%, ns). Treatment satisfaction was good and comparable across conditions. E-Getgoing patients expressed a preference for the Internet-based service, reporting convenience and increased confidentiality as major reasons. Integrating Internet-based group counseling with on-site treatment services could help expand the continuum of care in methadone maintenance clinics.

Entities:  

Mesh:

Year:  2008        PMID: 18775625     DOI: 10.1016/j.jsat.2008.06.011

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  29 in total

1.  An integrated videoconferencing intervention for chronic pain and heavy drinking among patients in HIV-care: a proof-of-concept study.

Authors:  Tibor P Palfai; Richard Saitz; Maya P L Kratzer; Jessica L Taylor; John D Otis; Judith A Bernstein
Journal:  AIDS Care       Date:  2020-06-11

Review 2.  The concomitant relationship shared by sleep disturbances and type 2 diabetes: developing telemedicine as a viable treatment option.

Authors:  Pennie S Seibert; Jennifer Valerio; CodieAnn DeHaas
Journal:  J Diabetes Sci Technol       Date:  2013-11-01

3.  Age and gender considerations for technology-assisted delivery of therapy for substance use disorder treatment: A patient survey of access to electronic devices.

Authors:  Denis Antoine; Sean Heffernan; Amina Chaudhry; Van King; Eric C Strain
Journal:  Addict Disord Their Treat       Date:  2016-12

Review 4.  Using technology in the delivery of mental health and substance abuse treatment in rural communities: a review.

Authors:  Sandra Benavides-Vaello; Anne Strode; Beth C Sheeran
Journal:  J Behav Health Serv Res       Date:  2013-01       Impact factor: 1.505

Review 5.  Internet-Based Interventions for Addictive Behaviours: A Systematic Review.

Authors:  Jaymee-Lee Chebli; Alexander Blaszczynski; Sally M Gainsbury
Journal:  J Gambl Stud       Date:  2016-12

Review 6.  The State and Sustainability of Telepsychiatry Programs.

Authors:  Carolyn Lauckner; Pamela Whitten
Journal:  J Behav Health Serv Res       Date:  2016-04       Impact factor: 1.505

7.  Integration of Technology-based Behavioral Health Interventions in Substance Abuse and Addiction Services.

Authors:  Alex Ramsey
Journal:  Int J Ment Health Addict       Date:  2015-08       Impact factor: 3.836

8.  An exploratory study of engagement in a technology-supported substance abuse intervention.

Authors:  Nancy R VanDeMark; Nicole R Burrell; Walter F Lamendola; Catherine A Hoich; Nicole P Berg; Eugene Medina
Journal:  Subst Abuse Treat Prev Policy       Date:  2010-06-08

9.  Utilization of communication technology by patients enrolled in substance abuse treatment.

Authors:  Erin A McClure; Shauna P Acquavita; Emily Harding; Maxine L Stitzer
Journal:  Drug Alcohol Depend       Date:  2012-10-26       Impact factor: 4.492

10.  A randomized trial of Web-based videoconferencing for substance abuse counseling.

Authors:  Van L King; Robert K Brooner; Jessica M Peirce; Ken Kolodner; Michael S Kidorf
Journal:  J Subst Abuse Treat       Date:  2013-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.